Slight Change in FDA's Drug Safety Communication Plan

The Food and Drug Administration has issued a new guidance document, "Drug Safety Information--FDA's Communication to the Public," explaining how it communicates important drug safety information and the factors influencing when information is communicated. This guidance replaces an earlier version issued in May 2005, when FDA proposed a new communication channel -- the "Drug Watch" Web page -- to provide information on emerging drug safety issues.

The agency said it decided to eliminate the name "Drug Watch" to prevent potential confusion with FDA's existing "MedWatch" of safety alerts.

Jeffrey Shuren, assistant commissioner for Policy, signed the notice that appeared in yesterday's Federal Register.

comments powered by Disqus

OH&S Digital Edition

  • OHS Magazine Digital Edition - June 2019

    June 2019

    Featuring:

    • ASSP SAFETY 2019 PREVIEW
      New Orleans Networking
    • NATION SAFETY MONTH
      Heed These Summer Safety Tips
    • TRAINING
      Education, Skill Development, and Behavior Change
    • SAFETY MANAGEMENT
      What Good Looks Like
    View This Issue